Cost–utility analysis and drug pricing of once‐weekly insulin icodec versus once‐daily insulin degludec for type 2 diabetes patients treated with basal insulin in China

Aim Insulin icodec is a first once‐weekly administration basal insulin analogue for type 2 diabetes. This study aimed to investigate the price range of icodec for type 2 diabetes in the Chinese market, taking insulin degludec as reference. Materials and Methods Long‐term health outcomes and costs fo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes, obesity & metabolism obesity & metabolism, 2024-12, Vol.26 (12), p.5995-6006
Hauptverfasser:	Hu, Shanshan, Wang, Shuowen, Gu, Shengying, Qi, Chendong, Shi, Chenyang, Fan, Guorong
Format:	Artikel
Sprache:	eng
Schlagworte:	China Cost-Benefit Analysis cost–utility analysis Diabetes Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - economics Drug Administration Schedule Drug Costs - statistics & numerical data drug pricing Female Glycated Hemoglobin - analysis Glycated Hemoglobin - metabolism Humans Hypoglycemic Agents - administration & dosage Hypoglycemic Agents - economics Hypoglycemic Agents - therapeutic use Insulin insulin degludec insulin icodec Insulin, Long-Acting - administration & dosage Insulin, Long-Acting - economics Insulin, Long-Acting - therapeutic use Male Middle Aged Quality-Adjusted Life Years Sensitivity analysis type 2 diabetes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!